Marshall Wace’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-288,446
| Closed | -$7.41M | – | 2753 |
|
|
2024
Q4 | $7.41M | Buy |
288,446
+178,322
| +162% | +$4.58M | 0.01% | 834 |
|
|
2024
Q3 | $1.83M | Buy |
110,124
+88,293
| +404% | +$1.47M | ﹤0.01% | 1297 |
|
|
2024
Q2 | $419K | Sell |
21,831
-93,549
| -81% | -$1.8M | ﹤0.01% | 1844 |
|
|
2024
Q1 | $2.73M | Buy |
115,380
+81,439
| +240% | +$1.93M | ﹤0.01% | 1084 |
|
|
2023
Q4 | $379K | Buy |
33,941
+23,777
| +234% | +$266K | ﹤0.01% | 1517 |
|
|
2023
Q3 | $94K | Sell |
10,164
-15,197
| -60% | -$141K | ﹤0.01% | 1732 |
|
|
2023
Q2 | $302K | Buy |
+25,361
| New | +$302K | ﹤0.01% | 1720 |
|